News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

EU Regulators Drop Antitrust Probe Into AstraZeneca PLC (AZN), Nycomed


3/1/2012 8:40:56 AM

European Union regulators dropped a probe into AstraZeneca Plc (AZN), the U.K.’s second-biggest drugmaker, and Takeda Pharmaceutical Co. (4502)’s Nycomed unit over possible collusion to keep cheaper copies of medicines off the market. “Our investigation did not enable us to conclude that AstraZeneca and Nycomed had infringed EU antitrust rules,” Antoine Colombani, a spokesman for the European Commission, said in an e-mail. “We are taking the issue of possible hindering or delaying of generic entry very seriously and we have several other ongoing antitrust investigations in the pharmaceutical sector.”

Read at News Release
Read at Bloomberg
Read at Wall Street Journal
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES